News
Don Valentine was diagnosed with early symptomatic Alzheimer’s disease, but, according to him and the doctors responsible for ...
As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on ...
Valley of Forgetting” by Jennie Erin Smith details the efforts of scientists to aid the people of a community in which ...
Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.
In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain inflammation.
A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...
Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's ...
New blood test developed by researchers can not only detect Alzheimer’s disease but also determine its stage, helps ...
A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...
GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.
Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results